FDA opens safety review of injectable RSV drugs approved for babies and toddlers

WASHINGTON (AP) — Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and toddlers from RSV, the respiratory virus that sends thousands of American children to the hospital each year.

The long-acting drugs from Merck and Sanofi are not vaccines, but the government review comes as health officials and advisers under Health Secretary Rober…